IDEXX Laboratories, Inc. Price Today
IDEXX Laboratories, Inc.
IDXX
Healthcare
$42.77B
💰
Market Cap
51.3
💸
Price to Earnings
$10.0
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
9 |
Strong Buy |
4 |
Hold |
6 |
Sell |
0 |
Strong Sell |
0 |
IDXX Price Forecast Target
514.7 👉 675.0 +31%
IDXX EPS Forecast
10.0 👉 12.7 +26%
Financials
Profit Margin
23 %
Revenue Growth
8.8 %
Dividend
$ 0
Held Percent
1.1% - Insiders
92.7% - Institutions
6.2% - Public
Major Fund Holders
-
💰 $
-
💰 $
-
💰 $
-
💰 $
-
💰 $
Stock Ideas
Steven Cohen Portfolio
Steven Cohen, the legendary trader and billionaire founder of Stamford-based SAC Capital, has established himself as a force to be reckoned with in the hedge fund industry. With a staggering net worth of $8 billion and an impressive $14 billion in …
Andreas Halvorsen Portfolio
Andreas Halvorsen is a Norwegian billionaire investor, hedge fund manager, and the founder of Viking Global Investors, a large hedge fund with over $50 billion in assets under management. He is known for his long-term, value-oriented investment appr…
Stanley Druckenmiller Portfolio
Stanley Druckenmiller is a legendary hedge fund manager who has made billions of dollars for his investors. His current portfolio is heavily invested in gold, silver, and other precious metals. He also owns shares in several technology and healthcar…
Paul Tudor Jones Portfolio
Paul Tudor Jones is a pioneer in macro trading and founder of Tudor Investment Corporation, one of the earliest pioneering hedge funds. With over 40 years of experience investing across global markets, Jones strategically allocates capital based on …📮FAQ
Some Frequently Asked Questions.
The IDEXX Laboratories, Inc. industry is Diagnostics & Research
The IDEXX Laboratories, Inc. sector is Healthcare
The IDEXX Laboratories, Inc. forecasted predicted Price to Earnings PE ratio is 40.5
The IDEXX Laboratories, Inc. Price to Earnings PE ratio is 51.3
The Market Capitalization of IDEXX Laboratories, Inc. is $42.77B
There are total of 82164596 float shares with 92.7% held by Institutions and 1.1% held by insiders
The MIDEXX Laboratories, Inc. forecasted Earnings per Share EPS is $12.7
The IDEXX Laboratories, Inc. Earnings per Share EPS is 10.0
The IDEXX Laboratories, Inc. company has $0 gross profits with 23 profit margins
The IDEXX Laboratories, Inc. Earnings Growth is 0.121% with 0.13% quarterly earnings growth
The IDEXX Laboratories, Inc. Revenue is $3660953088 with 0.088 revenue growth
The price target for IDEXX Laboratories, Inc. stock is $675.0 for the high target and $460.0 for the low target
The consensus analyst recommendations for IDEXX Laboratories, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for IDEXX Laboratories, Inc. is Buy, with the following breakdown:
- Buy: 9
- Strong Buy: 4
- Hold: 6
- Sell: 0
- Strong Sell: 0
The Beta of IDEXX Laboratories, Inc. is 1.3
The dividend of IDEXX Laboratories, Inc. is $0
The dividend yield of IDEXX Laboratories, Inc. is 0%
The biggest institutional and mutual fund holders of IDEXX Laboratories, Inc. stock are
The IDEXX Laboratories, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0